Verma Says CMS Taking Care To Get CAR-T Coverage Decision Right

CMS Administrator Seema Verma on Wednesday (May 22) said the agency is taking its time with a national Medicare coverage policy for new expensive hospital-administered cancer drugs, which was due to be published May 17 but was delayed, because the policy will affect coverage of drugs other than the two chimeric antigen receptor (CAR) T-cell therapies already on the market. “It’s not only new technology for the entire medical community, cancer care, but it’s also new ground for the agency,”...